Published on in Vol 5, No 2 (2016): Apr-Jun

Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol

Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol

Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol

Journals

  1. Wang D, Zhong L, Li M, Li J, Tran K, Ren L, He R, Xie J, Moser R, Fraser C, Kuchel T, Sena-Esteves M, Flotte T, Aronin N, Gao G. Adeno-Associated Virus Neutralizing Antibodies in Large Animals and Their Impact on Brain Intraparenchymal Gene Transfer. Molecular Therapy - Methods & Clinical Development 2018;11:65 View
  2. Stanford S, Pink R, Creagh D, Clark A, Lowe G, Curry N, Pasi J, Perry D, Fong S, Hayes G, Chandrakumaran K, Rangarajan S. Adenovirus‐associated antibodies in UK cohort of hemophilia patients: A seroprevalence study of the presence of adenovirus‐associated virus vector–serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A. Research and Practice in Thrombosis and Haemostasis 2019;3(2):261 View
  3. Guo P, Zhang J, Chrzanowski M, Huang J, Chew H, Firrman J, Sang N, Diao Y, Xiao W. Rapid AAV-Neutralizing Antibody Determination with a Cell-Binding Assay. Molecular Therapy - Methods & Clinical Development 2019;13:40 View
  4. Sierra-Delgado J, Likhite S, Bautista P, Gómez-Ochoa S, Echeverría L, Guío E, Vargas C, Serrano N, Meyer K, Rincon M. Prevalence of Neutralizing Antibodies against Adeno-Associated Virus Serotypes 1, 2, and 9 in Non-Injected Latin American Patients with Heart Failure—ANVIAS Study. International Journal of Molecular Sciences 2023;24(6):5579 View
  5. Zheng Z, Ye J, Leng M, Gan C, Tang N, Li W, Valencia C, Dong B, Chow H. Enhanced sensitivity of neutralizing antibody detection for different AAV serotypes using HeLa cells with overexpressed AAVR. Frontiers in Pharmacology 2023;14 View
  6. Li G, Tian S, Sun X, Zhao M, Zhang F, Zhang J, Cheng T, Zhang X. Leveraging CRISPR-Cas9 for Accurate Detection of AAV-Neutralizing Antibodies: The AAV-HDR Method. Human Gene Therapy 2024;35(13-14):490 View